Christel Renoux, MD, PhD
础蝉蝉辞肠颈补迟别听笔谤辞蹿别蝉蝉辞谤
Dr. Christel Renoux is a practicing neurologist from Lyon, France with expertise in multiple sclerosis and stroke as well as an epidemiologist. Following her MSc in Epidemiology from 平特五不中, she obtained a PhD in Neurosciences (option epidemiology) from Lyon 1 University, France. Moreover, she completed a postdoctoral fellowship with Dr. Suissa in the Department of Epidemiology at 平特五不中. On August 1st, 2012, she was appointed as an Assistant Professor in the Department of Neurology and Neurosurgery at 平特五不中 and Investigator at the Centre for Clinical Epidemiology at the Jewish General Hospital-Lady Davis Institute. Her research focuses on neuroepidemiology and pharmacoepidemiology mainly in multiple sclerosis and stroke.
Neuroepidemiology, pharmacoepidemiology
Dr. Renoux鈥檚 research program focuses on neuroepidemiology and pharmacoepidemiology. Using various large health databases, she evaluates the safety and effectiveness of medications, particularly related to neurological and psychiatric medications and outcomes, while applying advanced epidemiological methods. She also studies the epidemiology of cerebrovascular diseases in terms of risk factors, prevention and treatment. Her research has been funded by various organizations such as the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation, and Parkinson Canada.聽
Azoulay L, Dell'Aniello S, Simon T,聽Renoux C, Suissa S. The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost. 2013 Mar 5;109(3):431-9.
Ernst P,聽Renoux C, Dell'Aniello S, Suissa S. Pramipexole use and the risk of pneumonia. BMC Neurol. 2012 Sep 29;12:113
Renoux C, Dell'Aniello S, Brophy JM, Suissa S. Dopamine agonist use and the risk of heart failure. Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):34-41.